Liberty All-Star Equity Fund(USA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

USA Liberty All-Star Equity Fund

已收盘 05-22 16:00:00 EDT

5.81

+0.03

+0.52%

盘后5.80

-0.01-0.17%

18:31 EDT

最高5.82	最低5.78	成交量74.59万
今开5.80	昨收5.78	日振幅0.69%
总市值17.52亿	流通市值17.52亿	总股本3.02亿
成交额432.63万	换手率0.25%	流通股本3.02亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"USA","market":"US","secType":"STK","nameCN":"Liberty All-Star Equity Fund","latestPrice":5.81,"timestamp":1779480000000,"preClose":5.78,"halted":0,"volume":745910,"hourTrading":{"tag":"盘后","latestPrice":5.8,"preClose":5.81,"latestTime":"18:31 EDT","volume":1549,"amount":8982.67,"timestamp":1779489060827,"change":-0.01,"changeRate":-0.001721,"amplitude":0.003442},"delay":0,"changeRate":0.005190311418685011,"floatShares":301551615,"shares":301551615,"eps":0.556777,"marketStatus":"已收盘","change":0.03,"latestTime":"05-22 16:00:00 EDT","open":5.8,"high":5.82,"low":5.78,"amount":4326347.369630001,"amplitude":0.00692,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.556777,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1779782400000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":5.78,"dividendRate":0.117005,"preHourTrading":{"tag":"盘前","latestPrice":5.7983,"preClose":5.78,"latestTime":"08:59 EDT","volume":2701,"amount":15698.230907000001,"timestamp":1779454793845,"change":0.0183,"changeRate":0.003166,"amplitude":0.057474},"postHourTrading":{"tag":"盘后","latestPrice":5.8,"preClose":5.81,"latestTime":"18:31 EDT","volume":1549,"amount":8982.67,"timestamp":1779489060827,"change":-0.01,"changeRate":-0.001721,"amplitude":0.003442},"volumeRatio":0.800489},"requestUrl":"/m/hq/s/USA","defaultTab":"news","newsList":[{"id":"1121003754","title":"Aura Biosciences完成2.99亿美元公开发行 承销商超额配售权全额行使","url":"https://stock-news.laohu8.com/highlight/detail?id=1121003754","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121003754?lang=zh_cn&edition=full","pubTime":"2026-05-06 05:17","pubTimestamp":1778015852,"startTime":"0","endTime":"0","summary":"临床阶段生物技术公司Aura Biosciences, Inc.今日宣布完成此前公布的承销公开发行。本次发行中，公司以每股6.00美元的价格累计发售46,099,650股普通股，其中包含承销商全额行使超额配售权认购的6,508,650股。同时向特定投资者发行了可认购总计380万股普通股的预融资权证，行权价格为每份0.00001美元，权证发行价为每股5.99999美元。在扣除承销折扣及发行费用前，本次发行预计为Aura Biosciences募集约2.994亿美元总收益。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USA","AURA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189341988","title":"Cabaletta Bio定价1.5亿美元承销发行，礼来等多家机构参与认购","url":"https://stock-news.laohu8.com/highlight/detail?id=1189341988","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189341988?lang=zh_cn&edition=full","pubTime":"2026-05-04 18:37","pubTimestamp":1777891036,"startTime":"0","endTime":"0","summary":"临床阶段生物技术公司Cabaletta Bio近日宣布，其承销公开发行的5172.5万股普通股已完成定价。此次发行定价为每股2.90美元，与纳斯达克规则下的市价持平，预计在扣除承销折扣、佣金及发行费用前，募集资金总额将达1.5亿美元。发行计划预计于2026年5月5日左右完成，具体时间取决于惯例交割条件的满足情况。所有发行股份均由Cabaletta Bio售出。Cabaletta Bio是一家专注于为自身免疫性疾病患者开发治愈性靶向细胞疗法的生物技术公司。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4588","BK4555","USA","BK4604","TM","BK4585","CABA","03160","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157135932","title":"Apogee Therapeutics公布3.5亿美元承销公开发行定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1157135932","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157135932?lang=zh_cn&edition=full","pubTime":"2026-03-25 09:55","pubTimestamp":1774403756,"startTime":"0","endTime":"0","summary":"旧金山和波士顿，2026年3月24日——临床阶段生物技术公司Apogee Therapeutics, Inc.今日宣布，其先前公布的承销公开发行已完成定价。此次发行以每股70.00美元的公开发行价格，共计发行5,000,000股普通股。在扣除承销折扣、佣金以及Apogee应承担的其他发行费用之前，公司预计从此次发行中获得的总收益约为3.5亿美元。此外，Apogee已授予承销商一项为期30天的选择权，允许其以公开发行价额外购买最多750,000股普通股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USA","BK4132","BK4139","AD","APGE","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603659258","title":"Mdxhealth Sa盘中异动 早盘大幅拉升5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603659258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603659258?lang=zh_cn&edition=full","pubTime":"2026-01-14 00:19","pubTimestamp":1768321147,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日00时19分，Mdxhealth Sa股票出现异动，股价急速上涨5.54%。Mdxhealth Sa股票所在的生命科学行业中，整体跌幅为0.22%。其相关个股中，Revvity, Inc.、Mdxhealth Sa、Biodesix, Inc.涨幅较大，Biodesix, Inc.、Ispecimen Inc.、Mainz Biomed N.V.较为活跃，换手率分别为14.49%、13.35%、1.62%，振幅较大的相关个股有Ispecimen Inc.、Biodesix, Inc.、Precipio, Inc.，振幅分别为26.46%、17.88%、12.51%。Mdxhealth Sa公司简介：MDxHealth SA 是一家跨国医疗保健公司，提供可作的分子诊断信息，以个性化癌症的诊断和治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114001907953ca0b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114001907953ca0b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDXH","BK4196","BDSX","BK4139","USA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173182408","title":"Monte Rosa Therapeutics宣布拟公开发行普通股及预融资权证","url":"https://stock-news.laohu8.com/highlight/detail?id=1173182408","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173182408?lang=zh_cn&edition=full","pubTime":"2026-01-08 05:02","pubTimestamp":1767819763,"startTime":"0","endTime":"0","summary":"2026年1月7日，临床阶段生物技术公司Monte Rosa Therapeutics宣布启动承销公开发行，计划募集2亿美元资金。本次发行将包含公司普通股股份，并对特定投资者提供可认购普通股的预融资权证作为替代选择。所有发售股份及权证均由Monte Rosa提供。该公司同时授予承销商30天超额配售选择权，可额外认购最多3000万美元普通股。详细风险因素载于公司最新10-K年报及10-Q季报，Monte Rosa明确声明不承担更新前瞻性陈述的义务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","USA","BK4539","BK4555","BK4139","BK4585","BK4588","BK4604","BK4099","GLUE","03160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126414242","title":"新闻稿：Terns宣布拟进行公开募股","url":"https://stock-news.laohu8.com/highlight/detail?id=1126414242","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126414242?lang=zh_cn&edition=full","pubTime":"2025-12-09 19:15","pubTimestamp":1765278930,"startTime":"0","endTime":"0","summary":"加利福尼亚州福斯特城，2025年12月9日-- Terns Pharmaceuticals, Inc.，一家处于临床阶段的肿瘤学公司，今日宣布已开始进行4亿美元普通股的承销公开募股，并向某些投资者提供购买普通股的预售认购权证。此外，Terns预计将授予承销商一个30天的选择权，可以根据公开募股价格额外购买最多6000万美元的普通股。所有将在此次募股中售出的普通股和预售认购权证均将由Terns提供。此次募股受市场及其他条件的影响，无法保证该募股是否及何时会完成，或其实际规模和条款。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USA","BK4007","TERN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.all-starfunds.com","stockEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":0.0017},{"period":"3month","weight":-0.0415},{"period":"6month","weight":-0.0236},{"period":"1year","weight":-0.1242},{"period":"ytd","weight":-0.0796}],"compareEarnings":[{"period":"1week","weight":-0.0073},{"period":"1month","weight":0.0549},{"period":"3month","weight":0.0773},{"period":"6month","weight":0.127},{"period":"1year","weight":0.2743},{"period":"ytd","weight":0.0892}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Liberty All Star Equity Fund是马萨诸塞州的一家商业信托公司，根据1940年《投资公司法》（\"1940年法案\"）及其修订版注册，是一家多元化的封闭式管理投资公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.55,"avgChangeRate":0.010662},{"month":2,"riseRate":0.475,"avgChangeRate":-0.000234},{"month":3,"riseRate":0.55,"avgChangeRate":0.000825},{"month":4,"riseRate":0.55,"avgChangeRate":0.010848},{"month":5,"riseRate":0.525,"avgChangeRate":-0.004394},{"month":6,"riseRate":0.538462,"avgChangeRate":0.005641},{"month":7,"riseRate":0.538462,"avgChangeRate":0.008018},{"month":8,"riseRate":0.410256,"avgChangeRate":-0.020782},{"month":9,"riseRate":0.461538,"avgChangeRate":-0.009212},{"month":10,"riseRate":0.487179,"avgChangeRate":-0.003123},{"month":11,"riseRate":0.6,"avgChangeRate":-0.00139},{"month":12,"riseRate":0.625,"avgChangeRate":0.007434}],"exchange":"NYSE","name":"Liberty All-Star Equity Fund","nameEN":"Liberty All-Star Equity"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liberty All-Star Equity Fund(USA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Liberty All-Star Equity Fund(USA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Liberty All-Star Equity Fund,USA,Liberty All-Star Equity Fund股票,Liberty All-Star Equity Fund股票老虎,Liberty All-Star Equity Fund股票老虎国际,Liberty All-Star Equity Fund行情,Liberty All-Star Equity Fund股票行情,Liberty All-Star Equity Fund股价,Liberty All-Star Equity Fund股市,Liberty All-Star Equity Fund股票价格,Liberty All-Star Equity Fund股票交易,Liberty All-Star Equity Fund股票购买,Liberty All-Star Equity Fund股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liberty All-Star Equity Fund(USA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Liberty All-Star Equity Fund(USA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}